The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global opioids market reached a value of US$ XX Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Opioids are drugs used to control persistent and severe pain among patients suffering from chronic headaches and backaches. They interact with proteins in the brain, spinal cord, gut, and other parts of the body to block pain signals. They are either extracted from the poppy seeds or synthesized in the laboratory. They are generally available in the form of pills or as lozenges. They can also be administered into the vein via an intravenous (IV) injection or infusion and taken through oral and transdermal routes, wherein active ingredients are delivered across the skin for systemic distribution.
The rising prevalence of cancer on account of excessive tobacco and alcohol consumption and the occurrence of obesity, human papillomavirus (HPV), and multiple sunburns worldwide represents one of the key factors bolstering the market growth. This can also be attributed to the increasing geriatric population and the growing risk of developing cancer with age. Moreover, the rising number of individuals undergoing surgical interventions is positively influencing the sales of opioids across the globe as they help control post-surgical pain, speed recovery, and reduce the chances of complications, such as pneumonia and blood clots. Apart from this, the growing participation of children in professional sports and physical activities has led to an increase in the incidents of severe injuries. This, in confluence with the rising awareness among parents about the physical health of their children, is escalating the demand for opioids to manage severe pain. Furthermore, increasing investments in research and development (R&D) activities to assess the efficacy and safety of opioids in new diseases are projected to drive the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global opioids market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product type, application and distribution channel.
Breakup by Product Type:
Breakup by Application:
Breakup by Distribution Channel:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Boehringer Ingelheim International GmbH, Hikma Pharmaceuticals PLC, Mallinckrodt plc, Pfizer Inc., Purdue Pharma L.P., Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical Industries Ltd.
|Base Year of the Analysis||2020|
|Segment Coverage||Product Type, Application, Distribution Channel, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Boehringer Ingelheim International GmbH, Hikma Pharmaceuticals PLC, Mallinckrodt plc, Pfizer Inc., Purdue Pharma L.P., Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical Industries Ltd.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at